# AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA

Study · id `cardio:ct-nct03191240` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03191240](<https://clinicaltrials.gov/study/NCT03191240>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03191240

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT03191240. Randomized; triple masking; primary purpose treatment. Start 2017-12-31 (actual); primary completion 2021-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT03191240, source copy `cardio:ctgov-nct03191240-2022-03-08`, retrieved 2026-10-26)
- Started: 2017-12-31 (actual) (ClinicalTrials.gov record NCT03191240, source copy `cardio:ctgov-nct03191240-2022-03-08`, retrieved 2026-10-26)
- Primary completion: 2021-08-31 (actual) (ClinicalTrials.gov record NCT03191240, source copy `cardio:ctgov-nct03191240-2022-03-08`, retrieved 2026-10-26)
- Completion: 2021-08-31 (actual) (ClinicalTrials.gov record NCT03191240, source copy `cardio:ctgov-nct03191240-2022-03-08`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03191240, source copy `cardio:ctgov-nct03191240-2022-03-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03191240-2022-03-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA
- Condition: Out-of-Hospital Cardiac Arrest
- Intervention (Drug): Vasopressins
- Intervention (Drug): Normal saline
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Diastolic blood pressures and end tidal carbon dioxides during cardiopulmonary resuscitations and their association with outcomes in adult out-of-hospital cardiac arrest patients: A preplanned secondary analysis of the Augmented Medication CardioPulmonary resuscitation (AMCPR) trial (`cardio:pubmed-39952383`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7c46a3b708089f89ad48d9c24abcb53dba0f798ef91b0bb7ad74ccad3fc1f46c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
